Abu Dhabi [UAE], May 15 (ANI/WAM): Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi (DoH) has stated that the launch of Neuralink’s UAE-PRIME clinical trial in Abu Dhabi – the first international site outside North America – marks a powerful moment for the future of health.
He made the statements following the recent announcement by Neuralink regarding the launch of their first clinical trial in the Middle East, UAE-PRIME, at Cleveland Clinic Abu Dhabi in partnership with DoH, adding: “In collaboration with Cleveland Clinic Abu Dhabi, we are proud to enable the safe and responsible advancement of brain-computer interface technology, offering renewed hope to individuals living with severe neurological conditions.”
He noted that this partnership exemplifies “Abu Dhabi’s commitment to innovation in health and life sciences – driving the acceleration of breakthrough technologies that are purposefully tested, ethically governed, and made accessible to patients around the world.” (ANI/WAM)
Disclaimer: This story is auto-generated from a syndicated feed of ANI; only the image & headline may have been reworked by News Services Division of World News Network Inc Ltd and Palghar News and Pune News and World News
HINDI, MARATHI, GUJARATI, TAMIL, TELUGU, BENGALI, KANNADA, ORIYA, PUNJABI, URDU, MALAYALAM
For more details and packages
